Ramsay Generale de Sante SA

Ramsay Generale de Sante SA

9.44
EUR
-0.12
(-1.26%)
1.25BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
28.16
- -
27.21
27.31
29.52
40.23
33.94
36.45
38.97
42.6
45.51
47.17
48.76
- -
Basic EPS, GAAP
0.32
- -
0.45
0.7
0.1
0.1
0.12
0.59
1.07
0.45
-0.49
-0.49
-0.44
- -
Free Cash Flow per Basic Share
1.59
- -
1.06
1.31
1.99
0.42
5.08
4.31
0.62
3.87
3.8
4.99
3.45
- -
Dividend per Share
2.99
- -
- -
0.06
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
4.71
5.22
4.91
5.65
5.75
9.02
9.17
9.7
10.98
11.29
10.82
10.38
10.15
10.15
Tangible Book Value per Share
-3.95
-4.13
-4.49
-3.52
-3.76
-8.54
-8.78
-8.46
-9.94
-9.34
-9.93
-10.4
-10.45
-10.45
Basic Weighted Avg Shares
61
61
82
82
76
85
110
110
110
110
110
110
110
110
Sales/Revenue/Turnover
1,712
- -
2,227
2,234
2,242
3,401
3,746
4,023
4,301
4,702
5,007
5,208
5,381
- -
Operating Margin (%)
5.61
- -
6.24
5.93
5.61
4.61
4.93
6.61
6.83
4.67
3.68
3.6
3.66
- -
Depreciation Expense
110
- -
131
133
130
174
362
372
377
403
427
434
441
- -
Net Income, GAAP
20
- -
37
57
7
8
13
65
118
49
-54
-54
-48
- -
Effective Tax Rate (%)
56.25
- -
37.05
30.88
36.17
68.32
59.96
28.56
30.94
27.14
- -
- -
- -
- -
Profit Margin (%)
1.15
- -
1.66
2.55
0.33
0.24
0.36
1.62
2.75
1.05
-1.08
-1.04
-0.9
- -
Working Capital
-44
-24
-63
40
122
121
-51
-82
-230
-126
-219
-314
-336
-336
LT Debt
813
807
1,110
1,100
1,196
1,955
3,704
3,614
3,735
3,868
3,703
3,749
3,717
3,717
Total Equity
298
308
438
502
511
1,039
1,037
1,099
1,239
1,277
1,230
1,182
1,156
1,156
Return on Invested Capital (%)
3.78
- -
6.3
5.6
4.67
2.05
1.84
3.93
3.83
3.01
- -
- -
- -
- -
Return on Capital (%)
2.38
- -
4.14
4.54
1.29
0.87
1.47
2.9
3.71
2.78
- -
- -
- -
- -
Return on Common Equity (%)
5.38
- -
10.6
13.2
1.57
1.12
1.33
6.24
10.37
4.02
-4.42
-4.62
-4.26
- -

Capital Structure

EUR

•

in mil. unless spec.
Jun'25
Dec'26
Jun'26
ST Debt
335
326
337
LT Borrowings
1,858
1,907
1,868
LT Finance Leases
1,891
1,813
1,849
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
110
110
110
Market Capitalization
1,170
1,015
1,253

Working Capital

EUR

•

in mil. unless spec.
Jun'25
Dec'26
Jun'26
Total Current Assets
1,307
1,086
1,190
Cash, Cash Equivalents & STI
384
218
311
Accounts Receivable, Net
528
485
471
Inventories
125
129
131
Total Current Liabilities
1,621
1,410
1,526
Payables & Accruals
- -
- -
- -
ST Debt
335
326
337
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.15%
1.2%
-2.2%
Free Cash Flow
188.09%
86.53%
-30.88%
Net Income, GAAP
23.25%
-39.12%
-10.72%
Sales/Revenue/Turnover
10%
6.01%
3.33%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
5,007
2025
- -
- -
5,208
2026
- -
- -
5,381

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.49
2025
- -
- -
-0.49
2026
- -
- -
-0.44

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Pascal Roché
Full Time Employees
40,000
Sector
Health services
Industry
Hospital/Nursing management
Address
39 rue Mstislav Rostropovitch Paris IF France 75017
IPO Date
Jun 19, 2001
Business
Ramsay Générale de Santé S.A. (GDS.PA) operates as a leading private hospital group in France and Europe, providing comprehensive healthcare services through a network of hospitals, clinics, and specialized facilities; its core offerings encompass medicine, surgery, and obstetrics (MSO), primary care, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity treatment, ophthalmology, orthopedics, stomatology, pneumology, psychiatry, radiology, urology, thoracic surgery, vascular surgery, endovascular procedures, medical imaging, dialysis, emergency services, rehabilitation, follow-up care, home hospitalization, mental health treatment, addiction services, telemedicine, e-health, elderly care, nutrition, outpatient surgery, and sanitary transport. The company manages approximately 120 facilities, including 75 centers in France, with operations extending to Sweden, Norway, Denmark, and Italy, serving diverse patient needs from inpatient and outpatient care to specialized diagnostics and mental health support. Founded in 1987 and headquartered at 39 rue Mstislav Rostropovitch in Paris, France, Ramsay Générale de Santé S.A. functions as a subsidiary of Ramsay Health Care Limited, which holds a 52.79% stake alongside Prédica at 39.82%. In recent developments, the company acquired 11 Cosem primary care centers in June 2024 to bolster its primary medicine footprint; reported a 4.7% revenue increase to €5.2 billion for the fiscal year ending June 2025, driven by higher activity volumes and the Cosem integration; refinanced debt by extending its €425 million TLB3 facility for two years into a new Term Loan B5; and saw Ramsay Health Care Limited initiate a review of strategic options for its majority shareholding as of November 2025.